|
End-of-day quote
Moscow Micex - RTS
08/07/2022
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 1.36B 117B 1.17B 1.1B 1B 1.88B 129B 1.89B 12.99B 5.05B 65.43B 5.09B 4.98B 217B | P/E 2021 |
-2.42x | P/E 2022 | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 180B 1.8B 1.69B 1.54B 2.9B 199B 2.92B 20.04B 7.8B 101B 7.86B 7.69B 334B | EV / Sales 2021 |
5.43x | EV / Sales 2022 | 5.51x |
| Free-Float |
95.22% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +10.15% |
| 5 years | 2.64 |  | 7 |
| 10 years | 2.64 | | 18.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 31/12/2013 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dmitriy Genkin
CHM | Chairman | 57 | 31/12/2004 |
| Director/Board Member | 58 | - | |
Alexey Shafranov
BRD | Director/Board Member | 47 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.15% | -.--% | -.--% | -.--% | 25.27M | |
| -1.52% | -7.23% | +57.34% | +108.72% | 1,047B | |
| -0.82% | -2.63% | +49.30% | +64.43% | 646B | |
| +0.37% | -3.06% | +21.00% | +74.48% | 451B | |
| -1.64% | -4.75% | +35.59% | +35.54% | 355B | |
| -0.39% | -2.76% | +21.39% | +38.01% | 291B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -0.59% | -3.15% | +49.83% | +67.70% | 234B | |
| -1.05% | -2.29% | -19.91% | -54.10% | 203B | |
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | |
| Average | +0.39% | -1.39% | +24.59% | +43.76% | 365.93B | |
| Weighted average by Cap. | -0.77% | -3.46% | +36.51% | +64.76% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 438M 37.74B 377M 354M 323M 608M 41.71B 612M 4.2B 1.63B 21.15B 1.65B 1.61B 70.03B | 380M 32.69B 327M 307M 280M 526M 36.13B 530M 3.64B 1.42B 18.32B 1.43B 1.39B 60.65B |
| Net income | -698M -60.05B -601M -564M -515M -967M -66.37B -974M -6.68B -2.6B -33.66B -2.62B -2.56B -111B | -207M -17.86B -179M -168M -153M -288M -19.74B -290M -1.99B -773M -10.01B -779M -762M -33.15B |
| Net Debt | 693M 59.65B 597M 560M 511M 961M 65.93B 968M 6.64B 2.58B 33.43B 2.6B 2.55B 111B | 736M 63.38B 634M 595M 543M 1.02B 70.05B 1.03B 7.05B 2.74B 35.52B 2.76B 2.7B 118B |
Employees
59
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
